Literature DB >> 21403838

Tyr phosphatase-mediated P-ERK inhibition suppresses senescence in EIA + v-raf transformed cells, which, paradoxically, are apoptosis-protected in a MEK-dependent manner.

Stefania De Vitis1, Antonella Sonia Treglia, Luca Ulianich, Stefano Turco, Giuseppe Terrazzano, Angela Lombardi, Claudia Miele, Corrado Garbi, Francesco Beguinot, Bruno Di Jeso.   

Abstract

Activation of the Ras-Raf-extracellular signal-regulated kinase (ERK) pathway causes not only proliferation and suppression of apoptosis but also the antioncogenic response of senescence. How these contrasting effects are reconciled to achieve cell transformation and cancer formation is poorly understood. In a system of two-step carcinogenesis (dedifferentiated PC EIA, transformed PC EIA-polyoma-middle T [PC EIA + Py] and PC EIA-v-raf [PC EIA + raf] cells], v-raf cooperated with EIA by virtue of a strong prosurvival effect, not elicited by Py-middle T, evident toward serum-deprivation-and H(2)O(2)-induced apoptosis. Apoptosis was detected by DNA fragmentation and annexin V staining. The prosurvival function of v-raf was, in part, mitogen-activated protein kinase/ERK kinase (MEK)-dependent, as shown by pharmacological MEK inhibition. The MEK-dependent antiapoptotic effect of v-raf was exerted despite a lower level of P-ERK1/2 in EIA + raf cells with respect to EIA + Py/EIA cells, which was dependent on a high tyrosine phosphatase activity, as shown by orthovanadate blockade. An ERK1/2 tyrosine phosphatase was likely involved. The high tyrosine phosphatase activity was instrumental to the complete suppression of senescence, detected by β-galactosidase activity, because tyrosine phosphatase blockade induced senescence in EIA + raf but not in EIA + Py cells. High tyrosine phosphatase activity and evasion from senescence were confirmed in an anaplastic thyroid cancer cell line. Therefore, besides EIA, EIA + raf cells suppress senescence through a new mechanism, namely, phosphatase-mediated P-ERK1/2 inhibition, but, paradoxically, retain the oncogenic effects of the Raf-ERK pathway. We propose that the survival effect of Raf is not a function of absolute P-ERK1/2 levels at a given time but is rather dynamically dependent on greater variations after an apoptotic stimulus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21403838      PMCID: PMC3033591          DOI: 10.1593/neo.101152

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  46 in total

1.  Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1.

Authors:  H G Wang; S Takayama; U R Rapp; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Bcl-2 targets the protein kinase Raf-1 to mitochondria.

Authors:  H G Wang; U R Rapp; J C Reed
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

3.  Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not in normal differentiated thyroid cells.

Authors:  B di Jeso; L Ulianich; L Racioppi; F D'Armiento; A Feliciello; F Pacifico; E Consiglio; S Formisano
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575

Review 4.  The ins and outs of Raf kinases.

Authors:  G Daum; I Eisenmann-Tappe; H W Fries; J Troppmair; U R Rapp
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.

Authors:  E Bosch; H Cherwinski; D Peterson; M McMahon
Journal:  Oncogene       Date:  1997-08-28       Impact factor: 9.867

8.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.

Authors:  J R Fabian; I O Daar; D K Morrison
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  Characterization of murine A-raf, a new oncogene related to the v-raf oncogene.

Authors:  M Huleihel; M Goldsborough; J Cleveland; M Gunnell; T Bonner; U R Rapp
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

10.  Senescence of human fibroblasts induced by oncogenic Raf.

Authors:  J Zhu; D Woods; M McMahon; J M Bishop
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

View more
  11 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress.

Authors:  Angela Lombardi; Yaron Tomer
Journal:  J Autoimmun       Date:  2017-02-24       Impact factor: 7.094

4.  Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.

Authors:  Angela Lombardi; Erlinda Concepcion; Hanxi Hou; Hanane Arib; Mihaly Mezei; Roman Osman; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-09-17       Impact factor: 7.094

5.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

6.  Increased hexosamine biosynthetic pathway flux dedifferentiates INS-1E cells and murine islets by an extracellular signal-regulated kinase (ERK)1/2-mediated signal transmission pathway.

Authors:  A Lombardi; L Ulianich; A S Treglia; C Nigro; L Parrillo; D D Lofrumento; G Nicolardi; C Garbi; F Beguinot; C Miele; B Di Jeso
Journal:  Diabetologia       Date:  2011-10-18       Impact factor: 10.122

7.  Cytotoxic effects of oxytetracycline residues in the bones of broiler chickens following therapeutic oral administration of a water formulation.

Authors:  R Odore; M De Marco; L Gasco; L Rotolo; V Meucci; A T Palatucci; V Rubino; G Ruggiero; S Canello; G Guidetti; S Centenaro; A Quarantelli; G Terrazzano; A Schiavone
Journal:  Poult Sci       Date:  2015-05-25       Impact factor: 3.352

8.  Mechanical phenotyping of K562 cells by the Micropipette Aspiration Technique allows identifying mechanical changes induced by drugs.

Authors:  Alessandro Di Cerbo; Valentina Rubino; Francesca Morelli; Giuseppina Ruggiero; Rosaria Landi; Gianandrea Guidetti; Sergio Canello; Giuseppe Terrazzano; Andrea Alessandrini
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

9.  Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure.

Authors:  Angela Lombardi; Bruno Trimarco; Guido Iaccarino; Gaetano Santulli
Journal:  Cell Commun Signal       Date:  2017-11-13       Impact factor: 5.712

10.  Toxicological Implications and Inflammatory Response in Human Lymphocytes Challenged with Oxytetracycline.

Authors:  A Di Cerbo; A T Palatucci; V Rubino; S Centenaro; A Giovazzino; E Fraccaroli; L Cortese; G Ruggiero; G Guidetti; S Canello; G Terrazzano
Journal:  J Biochem Mol Toxicol       Date:  2015-11-05       Impact factor: 3.642

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.